Salt-sensitive hypertension: Lessons from animal models

American Journal of Kidney Diseases

Volumn 28, Issue 5, 1996, Pages 775-782

  Sanders, Paul W ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Dahl Rapp rat; Dietary salt; hypertension; L arginine; nitric oxide; nitric oxide synthase; renal failure; salt sensitivity

Indexed keywords

ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE;

ANIMAL MODEL; ARTICLE; HYPERTENSION; KIDNEY FAILURE; NONHUMAN; PATHOGENESIS; RAT; SALT INTAKE;

EID: 0029857499     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90265-6     Document Type: Article

References (79)

1. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376, 1980
2. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526, 1987
3. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269, 1987
4. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH: Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351:714-718, 1991
5. Lyons CR, Orloff GJ, Cunningham JM: Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267:6370-6374, 1992
6. Xie Q-W, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228, 1992
7. Lamas S, Marsden PA, Li GK, Tempst P, Michel T: Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 89:6348-6352, 1992
8. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ: Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 90:2092-2096, 1992
9. Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, D'Angelo DD, Lynch KR, Peach MJ: Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 267:15274-15276, 1992
10. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD: Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267:14519-14522, 1992
11. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR: Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90:3491-3495, 1993
12. Nunokawa Y, Ishida N, Tanaka S: Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun 191:89-94, 1993
13. Hibbs JB, Taintor RR, Vavrin Z: Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrate. Science 235:473-476, 1987
14. Marietta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS: Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate. Biochemistry 27:8706-8711, 1988
15. Leaf CD, Wishnok JS, Tannenbaum SR: L-arginine is a precursor for nitrate biosynthesis in humans. Biochem Biophys Res Commun 163:1032-1037, 1989
16. (1)-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 266:6259-6263, 1991
17. Sakuma I, Stuehr DJ, Gross SS, Nathan C, Levi R: Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85:8664-8667, 1988
18. Arnold WP, Mittal CK, Katsuki S, Murad F: Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 74:3203-3207, 1977
19. Rees DD, Palmer RMJ, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86:3375-3378, 1989
20. Rapoport RM, Draznin MB, Murad F: Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 306:174-176, 1983
21. Kukovetz WR, Holzmann S: Mechanisms of nitrate-induced vasodilatation and tolerance. Eur J Pharmacol 38:S9-S14, 1990 (suppl 1)
22. Mülsch A, Busse R, Bassenge E: Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses. Eur J Pharmacol 158:191-198, 1988
23. Moncada S, Rees DD, Schulz R, Palmer RMJ: Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 88:2166-2170, 1991
24. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239-242, 1995
25. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS: Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8:11-127-11-134, 1986 (Suppl II)
26. Dustan HP, Valdes G, Bravo EL, Tarazi RC: Excessive sodium retention as a characteristic of salt-sensitive hypertension. Am J Med Sci 292:67-74, 1986
27. Ward R: Familial aggregation and genetic epidemiology of blood pressure, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management (ed 2). New York, NY, Raven, 1995, pp 67-88
28. Tobian L: Salt and hypertension. Am J Nephrol 3:80-87, 1983
29. Grim CE, Wilson TW, Nicholson GD, Hassell TA, Fraser HS, Grim CM: Blood pressure in blacks. Twin studies in Barbados. Hypertension 15:803-809, 1990
30. Dustan HP, Curtis JJ, Luke RG, Rostand SG: Systemic hypertension and the kidney in black patients. Am J Cardiol 60:731-771, 1987
31. Dahl LK, Heine M, Tassinari L: Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194:480-482, 1962
32. Dahl LK, Heine M, Tassinari L: Effects of chronic excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med 115:1173-1190, 1962
33. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D: Prevalence of hypertension in the US adult population. Results from the third national health and nutrition examination survey, 1988-1991. Hypertension 25:305-313, 1995
34. Rostand SG, Kirk KA, Rutsky EA, Pate BA: Racial differences in the incidence of end stage renal disease. N Engl J Med 306:1276-1279, 1982
35. Ferguson R, Grim CE, Opgenorth TJ: A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol 41:1189-1196, 1988
36. Meneely GR, Ball COT: Experimental epidemiology of chronic sodium chloride toxicity and the protective effect of potassium chloride. Am J Med 25:713-725, 1958
37. Rapp JP, Dene H: Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 7:340-349, 1985
38. Chen PY, St John PL, Kirk KA, Abrahamson DR, Sanders PW: Hypertensive nephrosclerosis in the Dahl/Rapp rat: Initial sites of injury and effect of dietary L-arginine administration. Lab Invest 68:174-184, 1993
39. Greene AS, Yu ZY, Roman RJ, Cowley AW: Role of blood volume expansion in Dahl rat model of hypertension. Am J Physiol 258:H508-H514, 1990
40. Roman RJ, Kaldunski ML: Enhanced chloride reabsorption in the loop of Henle in Dahl salt-sensitive rats. Hypertension 17:1018-1024, 1991
41. Kirchner KA: Increased loop chloride uptake precedes hypertension in Dahl salt-sensitive rats. Am J Physiol 262:R263-R268, 1992
42. John SWM, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O: Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679-681, 1995
43. Deng AY, Dene H, Pravenec M, Rapp JP: Genetic mapping of two new blood pressure quantitative loci in the rat by genotyping endothelin system genes. J Clin Invest 93:2701-2709, 1994
44. Deng Y, Rapp JP: Cosegregation of blood pressure with angiotensin converting enzyme and atrial natriuretic peptide receptor genes using Dahl salt-sensitive rats. Nature Genet 1:267-272, 1992
45. Canessa CM, Horisberger JD, Rossier BC: Epithelial sodium channel related to proteins involved in neurodegeneration. Nature 361:467-470, 1993
46. Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger JD, Rossier BC: Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 367:463-467, 1994
47. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP: Liddle's syndrome: Heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79:407-414, 1994
48. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel J-M: A chimeric IIβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262-265, 1992
49. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC: Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxy steroid dehydrogenase. Nature Genet 10:394-399, 1995
50. Rees DD, Palmer RMJ, Hodson HF, Moncada S: A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 96:418-424, 1989
51. G-methylarginine. Biochem Biophys Res Commun 170:96-103, 1990
52. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172:1132-1138, 1990
53. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87:3629-3632, 1990
54. Chen PY, Sanders PW: L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88:1559-1567, 1991
55. Shultz PJ, Tolins JP: Adaptation to increased dietary salt intake in the rat: Role of endogenous nitric oxide. J Clin Invest 91:642-650, 1993
56. Deng X, Welch WJ, Wilcox CS: Renal vasoconstriction during inhibition of NO synthase: Effects of dietary salt. Kidney Int 46:639-646, 1994
57. Tolins JP, Shultz PJ: Endogenous nitric oxide synthesis determines sensitivity to the presser effect of salt. Kidney Int 46:230-236, 1994
58. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T: Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension 22:49-55, 1993
59. Chen PY, Sanders PW: Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 22:812-818, 1993
60. Lockette W, Otsuka Y, Carretero O: The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 8:11-61-11-66, 1986 (suppl II)
61. Lüscher TF, Raij L, Vanhoutte PM: Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 9:157-163, 1987
62. Lüscher TF, Vanhoutte PM, Raij L: Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension 9:III-193-III-197, 1987 (suppl III)
63. Wakabayashi Y, Yamada E, Yoshida T, Takahashi H: Deficiency of endogenous arginine synthesis provokes hypertension by exhausting substrate arginine for nitric oxide synthesis. Biochem Biophys Res Commun 205:1391-1398, 1994
64. Knowles RG, Salter M, Brooks SL, Moncada S: Antiinflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun 172:1042-1048,1990
65. Radomski MW, Palmer RMJ, Moncada S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 87:10043-10047, 1990
66. Bloch KD, Wolfram JR, Brown DM, Roberts JD, Jr, Zapol DG, Lepore JJ, Filippov G, Thomas JE, Jacob HJ, Bloch DB: Three members of the nitric oxide synthase II gene family (NOS2A, NOS2B, and NOS2C) colocalize to human chromosome 17. Genomics 27:526-530, 1995
67. Geng YJ, Almqvist M, Hansson GK: cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells. Biochim Biophys Acta 1218:421-424, 1994
68. Chen PY, Sanders PW: Functional and genetic abnormalities of inducible vascular smooth muscle nitric oxide synthase (NOS2b) in Dahl/Rapp salt-sensitive rats. (submitted)
69. Deng A, Rapp JP: Locus for the inducible, but not a constitutive, nitric oxide synthase cosegregates with blood pressure in the Dahl salt-sensitive rat. J Clin Invest 99:2170-2177, 1995
70. Patel A, Layne S, Watts D, Kirchner KA: L-arginine administration normalizes pressure natriuresis in the hypertensive Dahl rats. Hypertension 22:863-869, 1993
71. Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, Norman RA: Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52:584-594, 1972
72. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Diethelm AG: Remission of essential hypertension after renal transplantation. N Engl J Med 309:1009-1015, 1983
73. Mattson DL, Higgins DJ: Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension 27:688-692, 1996
74. Roczniak A, Burns KD: Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule. Am J Physiol 270:F106-F115, 1996
75. Stoos BA, Carretero OA, Garvin JL: Endothelial-derived nitric oxide inhibits sodium transport by affecting apical membrane channels in cultured collecting duct cells. J Am Soc Nephrol 4:1855-1860, 1994
76. Stoos BA, Garcia NH, Garvin JL: Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol 6:89-94, 1995
77. Hishikawa K, Nakaki T, Tsuda M, Esumi H, Ohshima H, Suzuki H, Saruta T, Kato R: Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J 33:41-48, 1992
78. Gaston RS, Schlessinger SD, Sanders PW, Barker CV, Curtis JJ, Warnock DG: Cyclosporine inhibits the renal response to L-arginine in human kidney transplant recipients. J Am Soc Nephrol 5:1426-1433, 1995
79. Nakaki T, Hishikawa K, Suzuki H, Saruta T, Kato R: L-arginine-induced hypotension. Lancet 336:696, 1990